Once-Weekly Pediatric Growth Hormone Snags FDA Approval
The FDA approved long-acting injectable somatrogon (Ngenla) for pediatric human…
Browsing Tag
OnceWeekly
Once-Weekly Insulin Icodec Bests Daily Insulin Options for Type 2 Diabetes
SAN DIEGO -- Investigational once-weekly insulin icodec outperformed once-daily insulin glargine U100 when it came…
Once-Weekly Insulin Icodec Wins; Wegovy Heart Data Soon; AACE’s T2D Algorithm…
Compared with once-daily insulin glargine U100, once-weekly icodec performed…
Once-Weekly TransCon™ CNP Achieved Primary Efficacy Objective, with Superiority at…
- Data demonstrated that once-weekly TransCon CNP has the potential to meet patient and caregiver needs for a safe, effective, tolerable and convenient treatment - The primary…
ADA: Once-Weekly Dulaglutide Ups Glycemic Control in Youth With T2D
Physician’s Briefing Staff
TUESDAY, June 7, 2022 (HealthDay News) -- For youth with type 2 diabetes, dulaglutide is superior to placebo for reducing…
Positive Results from VISEN’s Phase 3 Trial of Once-Weekly TransCon hGH in China…
- VISEN’s Phase 3 Trial achieved primary endpoint; pediatric growth hormone deficiency (GHD) patients treated with TransCon™ hGH demonstrated greater annualized height velocity at…